Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CRNXCRNX
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in <![CDATA[CRINETICS PHARMACEUTICALS INC]]>

Yes. Geode Capital Management holds 2,727,633 shares of CRNX (<![cdata[crinetics Pharmaceuticals Inc]]>), worth $102.1M, as of its Q2 2026 13F filing. It increased the position by 246,870 shares (+10.0%) from Q1 2026. Geode Capital Management has held CRNX in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$102.1M

Current Shares

2.7M

Total Value Change

+$7.6M

Total Shares Change

+879,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+9.9%
$102.1M0.0%$37.42
33
2026-Q1
Increased
2.5M
+10.6%
$90.1M0.0%$36.32
33
2025-Q4
Decreased
2.2M
-1.6%
$104.4M0.0%$46.55
0
2025-Q3
Increased
2.3M
+3.0%
$94.9M0.0%$41.65
31
2025-Q2
Increased
2.2M
+1.0%
$63.7M0.0%$28.76
30
2025-Q1
Increased
2.2M
+4.4%
$73.5M0.0%$33.54
31
2024-Q4
Increased
2.1M
+13.6%
$107.3M0.0%$51.13
34
2024-Q3
Increased
1.8M
+10.1%
$94.5M0.0%$51.10
33

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used